NO20005608L - Strukturelle proteiner fra fisk-pankreatisk-sykdomsvirus og anvendelser derav - Google Patents
Strukturelle proteiner fra fisk-pankreatisk-sykdomsvirus og anvendelser deravInfo
- Publication number
- NO20005608L NO20005608L NO20005608A NO20005608A NO20005608L NO 20005608 L NO20005608 L NO 20005608L NO 20005608 A NO20005608 A NO 20005608A NO 20005608 A NO20005608 A NO 20005608A NO 20005608 L NO20005608 L NO 20005608L
- Authority
- NO
- Norway
- Prior art keywords
- applications
- structural proteins
- pancreatic disease
- disease virus
- proteins
- Prior art date
Links
- 241000251468 Actinopterygii Species 0.000 title abstract 2
- 208000016222 Pancreatic disease Diseases 0.000 title abstract 2
- 101710172711 Structural protein Proteins 0.000 title abstract 2
- 241000700605 Viruses Species 0.000 title 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 102000004169 proteins and genes Human genes 0.000 abstract 3
- 238000009007 Diagnostic Kit Methods 0.000 abstract 1
- 231100000676 disease causative agent Toxicity 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
- C12N2770/36122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98201461 | 1998-05-08 | ||
| PCT/EP1999/003244 WO1999058639A2 (en) | 1998-05-08 | 1999-05-06 | Structural proteins of fish pancreatic disease virus and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20005608D0 NO20005608D0 (no) | 2000-11-07 |
| NO20005608L true NO20005608L (no) | 2000-11-07 |
| NO327754B1 NO327754B1 (no) | 2009-09-14 |
Family
ID=8233681
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20005608A NO327754B1 (no) | 1998-05-08 | 2000-11-07 | Strukturelle proteiner fra fisk-pankreatisk-sykdomsvirus, nukleotidsekvens, farmasoytisk preparat, DNA-vaksine, vektorvaksine, vaksine og diagnostisk sett. |
Country Status (9)
| Country | Link |
|---|---|
| US (4) | US6719980B1 (no) |
| EP (1) | EP1075523B1 (no) |
| JP (1) | JP4323720B2 (no) |
| AT (1) | ATE369429T1 (no) |
| CA (1) | CA2327353C (no) |
| DE (1) | DE69936774D1 (no) |
| DK (1) | DK1075523T3 (no) |
| NO (1) | NO327754B1 (no) |
| WO (1) | WO1999058639A2 (no) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6719980B1 (en) * | 1998-05-08 | 2004-04-13 | Akzo Nobel Nv | Structural proteins of fish pancreatic disease virus and uses thereof |
| US6936256B2 (en) * | 2001-08-10 | 2005-08-30 | University Of Maryland Biotechnology Institute | Sub-unit vaccine for infectious pancreatic necrosis virus |
| FR2887259B1 (fr) * | 2005-06-21 | 2007-09-14 | Agronomique Inst Nat Rech | CONSTRUCTION D'ADNc D'ALPHAVIRUS DE SALMONIDES |
| DK179025B1 (da) | 2005-09-16 | 2017-08-28 | Intervet Int Bv | Fiskevaccine |
| WO2009070929A1 (en) * | 2007-12-04 | 2009-06-11 | Schweitzer Co., Ltd. | A subunit vaccine for aquaculture |
| NO333242B1 (no) * | 2008-02-08 | 2013-04-15 | Pharmaq As | Sammensetning, medisinsk anvendelse og fremgangsmate som omfatter salmonid alfavirus |
| WO2011041789A1 (en) | 2009-10-02 | 2011-04-07 | The Trustees Of Columbia University In The City Of New York | Piscine reovirus immunogenic compositions |
| WO2012089749A1 (en) * | 2010-12-29 | 2012-07-05 | Intervet International B.V. | Salmonid alphavirus protein e2 |
| WO2012130723A1 (en) * | 2011-03-25 | 2012-10-04 | Intervet International B.V. | Salmonid alphavirus vaccine |
| US9303071B2 (en) * | 2012-09-17 | 2016-04-05 | Novartis Tiergesundheit Ag | Salmonid alphavirus and uses thereof |
| US10973908B1 (en) | 2020-05-14 | 2021-04-13 | David Gordon Bermudes | Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine |
| US12537071B1 (en) | 2020-07-22 | 2026-01-27 | David Gordon Bermudes | Bacteria having boolean control pathways expressing therapeutic proteins including immunotherapeutic cytotoxins |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9003978D0 (sv) * | 1990-12-13 | 1990-12-13 | Henrik Garoff | Dna expressionssystem baserade paa ett virus replikon |
| EP0712926B1 (en) | 1994-10-18 | 2003-10-08 | Akzo Nobel N.V. | Fish pancreatic disease virus |
| US5843712A (en) * | 1996-06-06 | 1998-12-01 | The Trustees Of Columbia University In The City Of New York | Sindbis virus expression system for recombinant antibody production |
| US6719980B1 (en) * | 1998-05-08 | 2004-04-13 | Akzo Nobel Nv | Structural proteins of fish pancreatic disease virus and uses thereof |
-
1999
- 1999-05-06 US US09/674,866 patent/US6719980B1/en not_active Expired - Lifetime
- 1999-05-06 CA CA2327353A patent/CA2327353C/en not_active Expired - Lifetime
- 1999-05-06 EP EP99950351A patent/EP1075523B1/en not_active Expired - Lifetime
- 1999-05-06 DK DK99950351T patent/DK1075523T3/da active
- 1999-05-06 WO PCT/EP1999/003244 patent/WO1999058639A2/en not_active Ceased
- 1999-05-06 DE DE69936774T patent/DE69936774D1/de not_active Expired - Lifetime
- 1999-05-06 JP JP2000548432A patent/JP4323720B2/ja not_active Expired - Lifetime
- 1999-05-06 AT AT99950351T patent/ATE369429T1/de not_active IP Right Cessation
-
2000
- 2000-11-07 NO NO20005608A patent/NO327754B1/no not_active IP Right Cessation
-
2004
- 2004-02-26 US US10/788,746 patent/US7341725B2/en not_active Expired - Lifetime
-
2007
- 2007-11-02 US US11/934,150 patent/US20080241179A1/en not_active Abandoned
-
2009
- 2009-09-30 US US12/570,963 patent/US8114409B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JP4323720B2 (ja) | 2009-09-02 |
| NO20005608D0 (no) | 2000-11-07 |
| NO327754B1 (no) | 2009-09-14 |
| DK1075523T3 (da) | 2007-12-27 |
| US6719980B1 (en) | 2004-04-13 |
| US20080241179A1 (en) | 2008-10-02 |
| DE69936774D1 (de) | 2007-09-20 |
| US8114409B2 (en) | 2012-02-14 |
| JP2002514407A (ja) | 2002-05-21 |
| CA2327353C (en) | 2010-09-21 |
| US20040258707A1 (en) | 2004-12-23 |
| CA2327353A1 (en) | 1999-11-18 |
| EP1075523B1 (en) | 2007-08-08 |
| EP1075523A2 (en) | 2001-02-14 |
| WO1999058639A2 (en) | 1999-11-18 |
| US7341725B2 (en) | 2008-03-11 |
| WO1999058639A3 (en) | 1999-12-29 |
| US20110123565A1 (en) | 2011-05-26 |
| ATE369429T1 (de) | 2007-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE154029T1 (de) | 7-deazapurin modifizierte oligonukleotide | |
| CY1109531T1 (el) | Πρωτεϊνες συντηξης του μυκοβακτηριδιου της φυματιωσης | |
| ATE252639T1 (de) | Modifizierter, das dorsalgewebe beeinflussender faktor | |
| NO20041917L (no) | Spesifikke midler som binder humant angiopoietin-2 | |
| NO20005608L (no) | Strukturelle proteiner fra fisk-pankreatisk-sykdomsvirus og anvendelser derav | |
| EP1001025A3 (en) | Outer membrane proteins from actinobacillus pleuropneumoniae | |
| DE60139544D1 (de) | Veränderte, fluoreszierende proteine | |
| TR200501541T2 (tr) | Leu-hirudinin e.coli ile kültür ortamında ayrışarak üretilmesinin sinyal sekansları | |
| DK1037916T3 (da) | Erythrovirus og dets anvendelser | |
| DE69426121D1 (de) | Gen grb3-3, variante und ihre verwendungen | |
| ATE482976T1 (de) | Defensinproteine | |
| DK1406927T3 (da) | Glycopeptider, fremstilling og anvendelse deraf til diagnosticering eller terapeutisk behandling af dissemineret sklerose | |
| NO20020573D0 (no) | Sekvens | |
| ATE346087T1 (de) | Hepatitis e-virus aus dem schwein und dessen verwendungen | |
| ATE462779T1 (de) | Nukleinsäurefreie ghost zusammensetzungen | |
| DK1159426T3 (da) | Kloning og udtryk af Haemophilus somnus transferrin-bindende proteiner | |
| ATE526400T1 (de) | Metalloproteaseproteine | |
| DE60229966D1 (de) | Diabetesmodell | |
| ATE353226T1 (de) | Adjuvanszusammensetzung enthaltend fha oder ein fha-fragment in freier form | |
| DE60129228D1 (de) | Humane 7-transmembranproteine und dafür codierende polynukleotide | |
| WO2001064840A8 (en) | Novel bone marrow nucleic acids and polypeptides | |
| PT1537210E (pt) | Inibicao de oliconucleotidos decoy de expressao cd-40 | |
| WO2002044382A8 (en) | Cytokine-like proteins | |
| WO2002050116A3 (en) | Adhesion molecule protein | |
| FR2767536B1 (fr) | Gene de la fievre mediterraneenne familiale |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| Filing an opposition |
Opponent name: NOVARTIS ANIMAL HEALTH INC, SCHWARZWALDALLEE 215 Effective date: 20100614 |
||
| MK1K | Patent expired |